Author

J. Pujol

Institutions: Heidelberg University, Centre Hospitalier Universitaire de Montpellier, Azienda Ospedaliera San Camillo-Forlanini, Jawaharlal Nehru Cancer Hospital and Research Centre, Hospital Universitario Virgen del Rocío

Observed institutions: Heidelberg University, Centre Hospitalier Universitaire de Montpellier, Azienda Ospedaliera San Camillo-Forlanini, Jawaharlal Nehru Cancer Hospital and Research Centre, Hospital Universitario Virgen del Rocío

OpenAlex ID: A5003563802

PARAMOUNT: Phase III study of maintenance pemetrexed (pem) plus best supportive care (BSC) versus placebo plus BSC immediately following induction treatment with pem plus cisplatin for advanced nonsquamous non-small cell lung cancer (NSCLC).

2011 · L. G. Paz-Ares, F. De Marinis, et al. · Journal of Clinical Oncology · 19

Works count: 1

Citation count: 19

H-index: 1

I10-index: 1